ZYLOXTB Shares Surge Over 13% Intraday on Strategic Investment in LIFETECH SCI with GL Capital

Deep News11-09

ZYLOXTB (02190) rose more than 13% during intraday trading, and as of press time, its shares were up 3.77% at HK$20.12, with a turnover of HK$7.84553 million.

On November 6, ZYLOXTB announced a joint strategic investment in LIFETECH SCI alongside GL Capital. Under the relevant agreement, ZYLOXTB and GL Capital will jointly establish GL Lighthouse Two Investment Limited ("Lighthouse Two") to subscribe to newly issued shares of LIFETECH SCI for a total of approximately HK$1.482 billion.

Upon completion of the transaction, Lighthouse Two will hold approximately 16.7% of LIFETECH SCI's total issued shares after the placement, becoming the single largest shareholder of LIFETECH SCI. ZYLOXTB plans to contribute approximately HK$889 million, holding a 60% stake in Lighthouse Two.

In addition, GL Capital plans to subscribe to 39.8 million newly issued shares of ZYLOXTB at HK$22 per share, representing 10.8% of the company's total shares (excluding treasury shares) after this issuance, providing funding support for the company's future further increase in its stake in LIFETECH SCI and overseas business development.

The subscription price represents a 13.5% premium over the closing price on the day the transaction was announced, and a 15.4% premium over the average closing price for the five trading days prior to the announcement, fully demonstrating GL Capital's recognition of ZYLOXTB's long-term development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment